U.S., Feb. 7 -- An application to own the trademark for 'SYNEXT' has been filed on Nov. 19, 2020.
Owner(s):
Biogency Pty Ltd; , P.O. Box 649, AUSTRALIA
Goods and/or Services:
For: dietary supplements; herbal dietary supplements; vitamin supplements; all for use to support nicotinamide adenine dinucleotide production, cell metabolism and energy production, maintain cardiovascular health, support blood capillary health, and relieve inflammation of joints
Class(es): 005, 006, 018, 044, 046, 051, 052
Mark Drawing Type: 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)
https://eog-tmng.uspto.gov/#/issueDate=2025-02-04&serialNumber=90330194
Disclaimer: Curated by HT Syndication....